tiprankstipranks
Marketing Alliance Inc (MAAL)
OTHER OTC:MAAL
US Market

Marketing Alliance (MAAL) AI Stock Analysis

29 Followers

Top Page

MAAL

Marketing Alliance

(OTC:MAAL)

Select Model
Select Model
Select Model
Neutral 58 (OpenAI - 5.2)
Rating:58Neutral
Price Target:
$1.50
▲(8.70% Upside)
Action:ReiteratedDate:03/24/26
The score is driven primarily by stable-to-mixed financial performance: improving leverage and a strong 2025 free-cash-flow rebound help, but sharp margin compression and earnings volatility are meaningful risks. Technical indicators are bearish with the stock below key moving averages and negative MACD, partially offset by a reasonable P/E valuation.
Positive Factors
Improving leverage
A steadily improving debt-to-equity ratio materially reduces financial risk and interest burden, increasing balance-sheet flexibility. Over the next 2–6 months this supports capital allocation optionality (debt paydown, investment or buffers) and lowers refinancing sensitivity.
Negative Factors
Sharp margin deterioration
Material margin compression halves operating profitability, reducing internal funding capacity and making the business more sensitive to cost shocks. If structural (pricing pressure or higher costs), margins could remain impaired for several quarters, limiting cash available for reinvestment.
Read all positive and negative factors
Positive Factors
Negative Factors
Improving leverage
A steadily improving debt-to-equity ratio materially reduces financial risk and interest burden, increasing balance-sheet flexibility. Over the next 2–6 months this supports capital allocation optionality (debt paydown, investment or buffers) and lowers refinancing sensitivity.
Read all positive factors

Marketing Alliance (MAAL) vs. SPDR S&P 500 ETF (SPY)

Marketing Alliance Business Overview & Revenue Model

Company Description
The Marketing Alliance, Inc. operates as a wholesale distributor of life insurance, annuities, and other financial service products in the United States. It also provides long term care insurance, disability insurance, and medicare supplement prod...

Marketing Alliance Financial Statement Overview

Summary
Mixed fundamentals. Revenue recovered in 2025, leverage improved (debt-to-equity down to ~0.49), and free cash flow rebounded strongly with earnings largely backed by cash (~0.98x). Offsetting this, profitability weakened sharply in 2025 (net margin ~2.2% vs. ~5.3% in 2024; EBIT/EBITDA margins roughly halved) and results have been volatile over the cycle.
Income Statement
56
Neutral
Balance Sheet
62
Positive
Cash Flow
71
Positive
BreakdownTTMJun 2024Jun 2023Jun 2022Mar 2021Jun 2020
Income Statement
Total Revenue17.41M21.37M19.59M17.38M24.34M32.14M
Gross Profit3.64M4.52M4.91M4.76M6.36M5.47M
EBITDA1.09M992.40K1.90M1.36M3.15M4.70M
Net Income823.12K465.60K1.04M893.63K2.62M1.44M
Balance Sheet
Total Assets13.29M15.84M17.50M18.53M23.39M24.94M
Cash, Cash Equivalents and Short-Term Investments3.71M4.67M6.36M6.10M6.83M6.85M
Total Debt1.13M2.65M4.29M4.83M5.56M6.12M
Total Liabilities7.44M10.41M10.78M11.64M15.61M17.63M
Stockholders Equity5.85M5.44M6.72M6.89M7.78M7.31M
Cash Flow
Free Cash Flow401.91K1.57M340.75K1.76M1.89M1.16M
Operating Cash Flow408.36K1.60M817.51K1.78M2.01M1.40M
Investing Cash Flow229.73K501.94K1.25M554.16K643.40K2.98M
Financing Cash Flow-1.16M-3.49M-1.62M-2.58M-2.63M-1.68M

Marketing Alliance Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price1.38
Price Trends
50DMA
1.32
Negative
100DMA
1.34
Negative
200DMA
1.36
Negative
Market Momentum
MACD
-0.02
Negative
RSI
48.21
Neutral
STOCH
62.59
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MAAL, the sentiment is Neutral. The current price of 1.38 is above the 20-day moving average (MA) of 1.26, above the 50-day MA of 1.32, and above the 200-day MA of 1.36, indicating a neutral trend. The MACD of -0.02 indicates Negative momentum. The RSI at 48.21 is Neutral, neither overbought nor oversold. The STOCH value of 62.59 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for MAAL.

Marketing Alliance Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
58
Neutral
$10.17M9.189.74%-59.57%
58
Neutral
$104.66M0.9513.52%13.16%
55
Neutral
$39.77M3.504.33%16.79%
46
Neutral
$16.65M0.174.56%19.30%-17.56%
41
Neutral
$25.02M-0.09-87.95%7.56%-344.04%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
MAAL
Marketing Alliance
1.27
-0.01
-0.78%
EHTH
Ehealth
1.28
-5.40
-80.84%
HUIZ
Huize Holding
1.65
-0.97
-37.02%
SLQT
SelectQuote
0.59
-2.75
-82.25%
GOCO
GoHealth
1.56
-10.72
-87.33%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 24, 2026